Recruiting
The STOP-MED CTRCD Trial
NCT06183437
- Conditions
- Antineoplastics Toxicity, Cancer, Cardiac Toxicity, +11 more
- Locations
-
- University of California, Los Angeles Los Angeles, California, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Baker Heart and Diabetes Institute Melbourne, Victoria, Australia
- Cardio-Oncology Clinic, MAHI, University of Alberta Hospital Edmonton, Alberta, Canada